Over 4 thousand U.S. patients with amyotrophic lateral sclerosis have been treated with RADICAVA

An announcement was made today by Mitsubishi Tanabe Pharma America Inc. that over 4 thousand people with amyotrophic lateral sclerosis in the U.S. have been given treatment with RADICAVA and more than 1 thousand and a hundred providers of healthcare…

FDA Approves Rapid Approval For Athersys for Acute Respiratory Syndrome

Athersys, Inc. (Nasdaq: ATHX) declared today that its clinical program assessing MultiStem® cell treatment for the treatment of Acute Respiratory Distress Syndrome (“ARDS”) has gotten Fast Track assignment from the United States Food and Drug Administration (“FDA”). This significant assignment…